March 2, 2023 NZeno, a New Zealand Company Agree to support eXCELL

We are very excited to announce that NZeno, a New Zealand biotech company is in the initial agreement to support eXCELL with the DSPF PIG tissues for xenogeneic cell product. The collaboration meeting was held with NZeno CEO, Dr. Tan and CSO, Dr. Garkavenko in Auckland on March 2, 2023.
NZeno is a company that develops medical research on Auckland Island pigs. The high health status of New Zealand’s pigs has made it possible for this country to be a leader in the development of xenogeneic cell therapy with cells from pig tissues.